Literature DB >> 33362223

Effects of neuromuscular training compared to classic strength-resistance training in patients with acute coronary syndrome: A study protocol for a randomized controlled trial.

Francisco José Ferrer-Sargues1, Óscar Fabregat-Andrés2,3, Isabel Martínez-Hurtado1, Pablo Salvador-Coloma1, Francisco José Martínez-Olmos1, Marta Lluesma-Vidal4, Gemma Biviá-Roig1, María José Segrera-Rovira1, María Dolores Arguisuelas1, Noemí Valtueña-Gimeno1.   

Abstract

The aim of the present clinical trial is to evaluate the effectiveness of neuromuscular versus classical strength-resistance training as part of a cardiac rehabilitation programme in patients following acute coronary syndrome. The study is designed as a double-blinded, randomised, and controlled clinical trial. Thirty participants suffering from acute coronary syndrome who meet our inclusion criteria will be recruited by a private tertiary hospital. The intervention group will follow 20 sessions of a cardiac rehabilitation programme divided into two parts: aerobic training and neuromuscular strength-resistance training. The control group will complete the same aerobic training as well as a classical strength-resistance training workout programme. The primary outcome of the study will be the mean difference in change from baseline in the Incremental Shuttle Walking Test. The secondary outcomes will be the cardiorespiratory fitness of the patients (assessed by means of the Chester Step Test), lower-limb performance (assessed with the 30-Second Chair Stand Test and Single-Leg Squat Test), lower-limb strength (hip flexor handheld dynamometry), sexual dysfunction assessment (Sex Health Inventory for Men) and quality of life (EQ-5D-5L). This work will provide evidence for the effectiveness of a neuromuscular versus a classic strength-training programme in terms of cardiorespiratory fitness, lower-limb performance capacities and quality of life, in cardiac patients. The data obtained could lead to more effective and functional workouts which, in turn, may enhance the speed at which these patients can return to their everyday activities of life and improve the efficiency of their movement patterns and heart responses. Furthermore, patients may find neuromuscular workout routines more motivating and engaging, thus encouraging them to adopt healthier lifestyle patterns.

Entities:  

Year:  2020        PMID: 33362223      PMCID: PMC7757882          DOI: 10.1371/journal.pone.0243917

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  40 in total

Review 1.  Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism.

Authors:  Mark A Williams; William L Haskell; Philip A Ades; Ezra A Amsterdam; Vera Bittner; Barry A Franklin; Meg Gulanick; Susan T Laing; Kerry J Stewart
Journal:  Circulation       Date:  2007-07-16       Impact factor: 29.690

2.  Aerobic fitness testing: an update.

Authors:  N Stevens; K Sykes
Journal:  Occup Health (Lond)       Date:  1996-12

3.  Measurement of physical performance by field tests in programs of cardiac rehabilitation: a systematic review and meta-analysis.

Authors:  Cristiane Travensolo; Karla Goessler; Roberto Poton; Roberta Ramos Pinto; Marcos Doederlein Polito
Journal:  Rev Port Cardiol (Engl Ed)       Date:  2018-04-13

4.  Training effects on peripheral muscle oxygenation and performance in children with congenital heart diseases.

Authors:  Wassim Moalla; Mohamed Elloumi; Karim Chamari; Grégory Dupont; Yves Maingourd; Zouhair Tabka; Said Ahmaidi
Journal:  Appl Physiol Nutr Metab       Date:  2012-05-04       Impact factor: 2.665

5.  Effect of active limb movements on symptoms in patients with low back pain.

Authors:  L R Van Dillen; S A Sahrmann; B J Norton; C A Caldwell; D Fleming; M K McDonnell; N J Bloom
Journal:  J Orthop Sports Phys Ther       Date:  2001-08       Impact factor: 4.751

6.  Aerobic interval training and continuous training equally improve aerobic exercise capacity in patients with coronary artery disease: the SAINTEX-CAD study.

Authors:  Viviane M Conraads; Nele Pattyn; Catherine De Maeyer; Paul J Beckers; Ellen Coeckelberghs; Véronique A Cornelissen; Johan Denollet; Geert Frederix; Kaatje Goetschalckx; Vicky Y Hoymans; Nadine Possemiers; Dirk Schepers; Bharati Shivalkar; Jens-Uwe Voigt; Emeline M Van Craenenbroeck; Luc Vanhees
Journal:  Int J Cardiol       Date:  2014-10-25       Impact factor: 4.164

7.  Random allocation software for parallel group randomized trials.

Authors:  Mahmood Saghaei
Journal:  BMC Med Res Methodol       Date:  2004-11-09       Impact factor: 4.615

8.  Single leg squat performance in physically and non-physically active individuals: a cross-sectional study.

Authors:  Silvia Gianola; Greta Castellini; Elena Stucovitz; Alice Nardo; Giuseppe Banfi
Journal:  BMC Musculoskelet Disord       Date:  2017-07-14       Impact factor: 2.362

9.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Authors:  Marco Roffi; Carlo Patrono; Jean-Philippe Collet; Christian Mueller; Marco Valgimigli; Felicita Andreotti; Jeroen J Bax; Michael A Borger; Carlos Brotons; Derek P Chew; Baris Gencer; Gerd Hasenfuss; Keld Kjeldsen; Patrizio Lancellotti; Ulf Landmesser; Julinda Mehilli; Debabrata Mukherjee; Robert F Storey; Stephan Windecker
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

10.  Effects of neuromuscular training (NEMEX-TJR) on patient-reported outcomes and physical function in severe primary hip or knee osteoarthritis: a controlled before-and-after study.

Authors:  Eva Ageberg; Anna Nilsdotter; Eva Kosek; Ewa M Roos
Journal:  BMC Musculoskelet Disord       Date:  2013-08-08       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.